SAN CARLOS, Calif.-- October 14, 2026 -- Altay Therapeutics, Inc., a biotechnology company developing novel small molecule inhibitors of transcription factors, today announced the completion of a $37 million Series...

Art Pappas will speak at the Personalized Medicine in North Carolina: Innovation to Application conference that will be held in Research Triangle Park, NC: "Investors Perspectives on Investments in Personalized Medicine"
News | 05. 11. 2009